StratifAI

StratifAI develops Polaris™, an AI-based biomarker platform that integrates histology, RNASeq, and patient outcomes to provide insights into spatial biology for precision oncology. The company's first diagnostic tool, Polaris™ Breast, assesses metastatic risk in early breast cancer directly from digitized histology slides to refine adjuvant treatment options. The platform is designed for use by clinicians and researchers in healthcare and life sciences environments to support evidence-based prognosis and treatment decisions.